Why Nigeria Must Strengthen its Local Pharmaceutical Manufacturing Capacity
With over 115 registered pharmaceutical manufacturers, Nigeria still depends on other countries for the supply of active pharmaceutical ingredients and excipients. Significant attention has not been paid to the local production of raw materials, pharmaceutical dosage formulations, or processing equi...
Saved in:
Main Authors: | Melody Okereke (Author), Adebowale Adekunbi (Author), Yusuf Ghazali (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The State of Pharmaceutical Manufacturing in the Democratic Republic of Congo: The Journey so Far
by: Melody Okereke
Published: (2022) -
An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
by: Melody Okereke, et al.
Published: (2022) -
Spread of the delta coronavirus variant: Africa must be on watch
by: Melody Okereke
Published: (2021) -
The Urgent Need to Intensify Vaccine Development and Manufacturing in Africa: Lessons from Emerging Pandemics
by: Melody Okereke, et al.
Published: (2022) -
How pharmaceutical industries can address the growing problem of climate change
by: Melody Okereke
Published: (2021)